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USEFUL LINKS  
 
           
 
(Please note that the inclusion of links to external sites should not be taken as an endorsement of that site by the SGC in any way) 
 
SUMMARY OF PROJECT  
 
In an effort to characterise the human NUDIX family SGC Oxford has expressed recombinant human NUDT7 
as part of the SGC chemical probe programme and solved the first crystal structure of this enzyme. This 
enabled a crystallographic fragment screen which in conjunction with a separate covalent fragment 
approach yielded a first-in-class small molecule inhibitor of NUDT7 with activity in the single-digit 
micromolar range in a catalytic assay. This compound paves the way for chemical probe development and 
further functional exploration of NUDT7 in physiological and disease contexts. 
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SCIENTIFIC BACKGROUND  
 
NUDT7 is part of a protein family characterised by a 23-amino acid motif referred to as the ‘NUDIX box’. 
These proteins have been reported to hydrolyse a diverse range of substrates including (d)NTPs, nucleotide 
sugars, diadenosine polyphosphates as well as capped RNA and dinucleotide coenzymes (1). NUDT7 is a 
peroxisomal CoA pyrophosphohydrolase with additional distinct sequence features such as a CoA-binding 
motif (NUDIX CoA signature, UPF0035) and a C-terminal peroxisomal targeting signal (PTS) (2,3). Expression 
of NUDT7 is highest in liver, with NUDT19 likely acting as the complementary CoA and CoA ester hydrolase 
in kidney (4). Leptin double knockout mice, which display alterations in CoA homeostasis and exhibit a 
diabetic phenotype, have been reported to express reduced levels of Nudt7 with a concomitant increase in 
pantothenate kinase activity (5). Conversely, neuronal overexpression of a cytosolic version of Nudt7 in mice 
leads to a reduction in motor coordination reminiscent of pantothenate kinase-associated neuro-
degeneration (PKAN), a neurodegenerative disease linked to reduced CoA levels (6). 
 
RESULTS – THE TEP 
 
Protein Production 
 
Recombinant human NUDT7 (residues 14-235) was expressed in E. coli. 
 
Structures 
 
Several high resolution crystal structures (1.52-2.21 Å) of human NUDT7 including apo and fragment-bound 
structures have been obtained and deposited in the PDB. 
 
First crystal structure of hNUDT7 (2.03 Å, PDB: 5T3P) 
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Overview of NUDT7 subunit with bound fragments 
 
 
Assays 
 
To confirm activity of the recombinant protein and enable chemical probe development we established a 
mass spectrometry-based assay to monitor acetyl-CoA hydrolysis by NUDT7. 
 
 
 
 
 
Chemical Matter 
A crystallographic fragment soaking campaign using XChem delivered several hits from chemical different 
libraries which were optimised to compounds with single-digit micromolar activity. 
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Superimposition of fragment crystal structures and covalent inhibitor lead derived from fragment merging (IC50 value 
1-3 µM, LE value 0.29-0.32)  
 
PDBID Ligand Binding Location Binding pocket Resolution (Å) 
5QGG 
 
FM002318a 
  
1.91 
5QGH 
 
FM010069a 
 
  
1.82 
5QGI 
 
FM002204a 
  
1.95 
5QGJ 
 
FM002197a 
  
1.95 
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5QGK 
 
FM001984a 
Location 1 
 
 
1.81 
Location 2 
 
 
Location 3 
  
5QGL 
 
XS022626c 
  
2.27 
5QGM 
 
FM010686a 
  
1.95 
5QGN 
 
FM010687a 
Location 1 
  
1.95 
Sussex one?
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Location 2 
 
 
5QGO,  
5QGP  
NU000598b, 
NU000598c 
5QGO 
 
 
1.82 
5QGP 
  
2.09 
5QGQ 
 
FM010688a 
  
1.95 
5QGR 
 
FM001790a 
Location 1 
  1.96 
Location 2 
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5QGS 
 
FM001898a 
  
1.55 
5QGT 
 
FM001898a 
  
1.97 
5QGU 
 
FM002048a 
  
1.71 
5QGV 
 
XS081083b 
  
1.59 
5QGW 
 
NU000082a 
  
1.94 
5QGX 
 
NU000083a 
  
1.61 
5QGY 
 
NU000090a 
  
1.72 
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5QGZ 
 
NU000098a 
  
1.65 
5QH0 
 
NU000135a 
  
1.57 
5QH1 
 
NU000087a 
  
1.65 
5QH2 
 
NU000088a 
  
1.74 
5QH3 
 
NU000154a 
Location 1 
 
 
1.65 
Location 2 
  
5QH4 
 
NU000057a 
  
1.67 
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5QH5 
 
NU000073a 
  
1.85 
5QH6 
 
NU000056a 
  
1.57 
5QH7 
 
NU000160a 
  
1.74 
5QHF 
 
NU000004a 
  
1.67 
5QH8 
 
NU000792a 
  
1.75 
5QH9 
 
NU000795a 
  
1.72 
5QHA 
 
NU000794a 
  
1.57 
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5QHG 
 
NU000442a 
  
1.92 
5QHH 
 
NU000443a 
  
1.52 
5QHB 
 
NU000610a 
  
1.57 
5QHC 
 
NU000612a 
  
2.21 
5QHE 
 
NU000621a 
  
1.74 
IMPORTANT: Please note that the existence of small molecules within this TEP only indicates that chemical matter can 
bind to the protein in a functionally relevant pocket. As such, these molecules should not be used as tools for functional 
studies of the protein unless otherwise stated as they are not sufficiently potent or well-characterised to be used in 
cellular studies. The small molecule ligands are intended to be used as the basis for future chemistry optimisation to 
increase potency and selectivity and yield a chemical probe or lead series. 
 
Future plans 
Looking forward, we plan to develop a chemical probe for NUDT7 based on the current lead molecule. 
 
Collaborations 
We would like to thank our collaborators Nir London (The Weizmann Institute of Science) and John Spencer 
(University of Sussex) on their work on NUDT7 inhibitor development. 
 
CONCLUSION  
Sussex one?
Sussex one?
Sussex one?
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We have generated active recombinant protein, developed a functional assay, and solved the first crystal 
structures of human NUDT7 in apo form and in complex with first-in-class chemical starting points enabling 
further inhibitor development and functional exploration of NUDT7. 
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ADDITIONAL INFORMATION 
Structure Files 
PDB ID Structure Details Library/ Series 
5T3P Structure of Human Peroxisomal coenzyme A diphosphatase NUDT7  
5QGG NUDT7 in complex with fragment DSPL 
5QGH NUDT7 in complex with fragment DSPL 
5QGI NUDT7 in complex with fragment DSPL 
5QGJ NUDT7 in complex with fragment DPSL 
5QGK NUDT7 in complex with fragment DSPL 
5QGL NUDT7 in complex with fragment DSPL 
5QGM NUDT7 in complex with fragment OxXChem 
5QGN NUDT7 in complex with fragment OxXChem 
5QGO NUDT7 in complex with fragment OxXChem 
5QGP NUDT7 in complex with fragment OxXChem 
5QGQ NUDT7 in complex with fragment DSPL 
5QGR NUDT7 in complex with fragment DSPL 
5QGS NUDT7 in complex with fragment DSPL 
5QGT NUDT7 in complex with fragment DSPL 
5QGU NUDT7 in complex with fragment DPSL 
5QGV NUDT7 in complex with fragment 3-chloro-phenylamino 
5QGW NUDT7 in complex with fragment 3-chloro-phenylamino 
5QGX NUDT7 in complex with fragment 3-chloro-phenylamino 
5QGY NUDT7 in complex with fragment 3-chloro-phenylamino 
5QGZ NUDT7 in complex with fragment 3-chloro-phenylamino 
5QH0 NUDT7 in complex with fragment 3-chloro-phenylamino 
5QH1 NUDT7 in complex with fragment 3-chloro-phenylamino 
5QH2 NUDT7 in complex with fragment 3-chloro-phenylamino 
5QH3 NUDT7 in complex with fragment 3-chloro-phenylamino 
5QH4 NUDT7 in complex with fragment 3-chloro-phenylamino 
5QH5 NUDT7 in complex with fragment 3-chloro-phenylamino 
5QH6 NUDT7 in complex with fragment 3-chloro-phenylamino 
5QH7 NUDT7 in complex with fragment 3-chloro-phenylamino 
5QHF NUDT7 in complex with fragment 3-chloro-phenylamino 
5QH8 NUDT7 in complex with fragment London 
5QH9 NUDT7 in complex with fragment London 
5QHA NUDT7 in complex with fragment London 
5QHG NUDT7 in complex with fragment FU covalent 
5QHH NUDT7 in complex with fragment FU covalent 
5QHB NUDT7 in complex with fragment Pyrrolidine 
5QHC NUDT7 in complex with fragment Pyrrolidine 
5QHE NUDT7 in complex with fragment Pyrrolidine 
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Materials and Methods 
 
Expression and purification of recombinant human NUDT7 
 
Human NUDT7 (residues 14-235) was cloned into pNIC28-Bsa4 with a TEV-cleavable N-terminal hexahistidine 
tag. After transformation into E. coli (BL21(DE3)-R3), expression was performed in TB auto induction medium 
(FroMedium), supplemented with 20 g/L glycerol, 50 μg/mL kanamycin and 34 μg/mL chloramphenicol. 
Cultures were grown for four hours at 37 °C, then the temperature was decreased to 20 °C and the cultures 
were grown for another 20 hours. Cells were spun at 5000 rpm for 10 min, then resuspended in 0.5 mg/mL 
lysozyme, 1 µg/mL benzonase, 20 mM imidazole and stirred for 2 hours at room temperature.  1% Triton X-
100 was added and the cells were frozen at -80°C. On thawing, cells were centrifuged for 1 hour at 4000 × g 
and the supernatant applied to a His GraviTrap column (GE healthcare) equilibrated with binding buffer 
(10 mM HEPES, 5% glycerol, 500 mM NaCl, 0.5 mM TCEP, pH 7.5). After washing with binding buffer 
supplemented to 20 mM imidazole, NUDT7 was eluted with buffer supplemented to 500 mM imidazole. The 
eluted protein was applied to a PD-10 desalting column (GE Healthcare) and eluted with binding buffer 
supplemented to 20 mM imidazole. The N-terminal affinity tag was removed by TEV cleavage overnight and 
uncleaved protein was removed by applying it again to a His GraviTrap column. The flow-through was 
concentrated and purified further by size exclusion chromatography using a YARRA SEC-2000 PREP column 
(Phenomenex) equilibrated with binding buffer. Fractions containing protein were pooled, concentrated and 
stored at -80°C. 
 
Crystallization 
 
NUDT7 crystals were obtained by mixing 100 nL of 30mg/mL protein in 10 mM Na-HEPES pH 7.5, 500 mM 
NaCl, 5% glycerol with 50 nL of reservoir solution containing 0.1M BisTris pH 5.5, 0.1M ammonium acetate 
and 6%(w/v) PEG10.000. Compact, hexagon-shaped crystals with typical dimensions between 50 – 100 µm 
appeared within several days from sitting drop plates at 293K.  An ECHO 550 acoustic liquid handler (Labcyte) 
was used to transfer individual fragments from the DSPL (7) and OxXChem (8) fragment library to crystal 
drops. Briefly, 38 nL of compound solution was added to each crystallisation drop resulting in a final 
compound concentration of 100 mM with 20% DMSO, calculated based on the initial drop volume. 
Compounds from the 3-chloro-phenylamino series were soaked into NUDT7 crystals by adding a mixture 
containing 600 nL of 100 mM compound in DMSO and 1200 nL of reservoir solution containing 0.1 M BisTris 
pH 5.5, 0.1M ammonium acetate and 10% (w/v) PEG10.000. Crystals were incubated overnight at room 
temperature and then harvested (without further cryoprotection) and flash cooled in liquid nitrogen. Crystals 
of NUDT7 with covalent binders were grown by mixing 100 nL of 30 mg/mL protein in 10 mM Na-HEPES 
pH 7.5, 500 mM NaCl, 5% glycerol with 30 nL of 20 mM compound in DMSO in sitting-drop crystallization 
plates containing 0.1 M BisTris pH 5.5, 0.1M ammonium acetate and 4 - 16% (w/v) PEG 10.000  in the 
reservoir at 293 K. After overnight incubation of protein and compound, 100 nL of reservoir solution and 
30 nL  of a crystal seed solution obtained from a previous crystallisation experiment, diluted 1:4 from the 
stock in 0.1 M BisTris pH 5.5, 0.1 M ammonium acetate and 9% (w/v) PEG 10.000 were added to the drop. 
Hexagon-shaped crystals appeared within several days. Prior to data collection, all crystals were transferred 
to a solution consisting of the precipitation buffer supplemented with 25% ethylene glycol and subsequently 
flash cooled in liquid nitrogen. All X-ray diffraction data were collected on the beamline I04-1 at Diamond 
Light Source (Harwell, UK) unless stated otherwise. 
 
Structure determination 
 
Diffraction data were automatically processed by software pipelines at the Diamond Light Source (9). Initial 
refinement and map calculation was carried out with DIMPLE (10). PanDDA (11) was used for hit identification 
and further refinement and model building was performed with REFMAC (12) and COOT (13), respectively. 
All structure determination steps were performed within the XChemExplorer (14) data management and 
workflow tool. 
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Coordinates and structure factors for all data sets are deposited in the RCSB Protein Data Bank under group 
deposition ID G_1002045. Data collection and refinement statistics are available from the PDB pages. The 
complete PanDDA analysis and processed data from all crystals (including information about soaked 
compounds) that were prepared as part of the NUDT7 project can be accessed via the ZENODO data 
repository under DOI 10.5281/zenodo.1244111. 
 
NUDT7 activity assay 
 
Mass spectrometry assays monitoring acetyl-CoA hydrolysis by NUDT7 were performed on a Agilent 6530 
RapidFire QTOF Mass Spectrometer in a 384-well plate format using polypropylene plates (Greiner, code 
781280) and an assay buffer containing 20 mM HEPES pH 7.5, 200 mM NaCl and 5 mM MgCl2. All bulk liquid 
handling steps were performed using a multidrop combi reagent dispenser (Thermo Scientific, Code 5840300) 
equipped with a small tube plastic tip dispensing cassette (Thermo Scientific, Code 24073290). For inhibitor 
IC50 determinations an 11-point and 2-fold serial dilution in was prepared from a 50 mM stock solution in 
DMSO which was transferred to give four replicates using an ECHO 550 acoustic dispenser (Labcyte).  The 
transferred volume was 400 nL giving a final DMSO concentration of 0.4%. In addition, a DMSO control (400 
nL) was transferred into alternate wells in columns 12 and 24 and 50 mM EDTA (NUDT7 inhibitor) was 
dispensed into alternate wells of column 24 as the background control. 80 µL assay buffer was added to all 
wells and NUDT7 was prepared to 500 nM (10 X final concentration in assay buffer) and acetyl-CoA was 
prepared to 200 µM (10 X final concentration in assay buffer). 10 µL NUDT7 was dispensed into half of the 
assay plate (for two of the compound replicates) and the plate was incubated at room temperature for 30 
minutes.   10 µL NUDT7 was then dispensed into the remaining half of the assay plate (for the remaining two 
compound replicates).   10 µL acetyl-CoA was immediately dispensed into all wells of the assay plate to initiate 
the reaction and the enzyme reaction was allowed to proceed for 15 min.  The enzyme reaction was stopped 
by addition of 10 uL of 50 mM EDTA and the plate was transferred to a RapidFire RF360 high throughput 
sampling robot. Samples were aspirated under vacuum and loaded onto a C4 solid phase extraction (SPE) 
cartridge equilibrated and washed for 5.5 sec with 1 mM octylammonium acetate in LCMS grade water to 
remove non-volatile buffer components. After the aqueous wash, analytes of interest were eluted from the 
C4 SPE onto an Agilent 6530 accurate mass Q-TOF in an organic elution step (85% acetonitrile in LC-MS grade 
water). Ion data for the acetyl-CoA and hydrolysed product were extracted and peak area data integrated 
using RapidFire integrator software (Agilent). % conversion of substrate to product was calculated in Excel 
and IC50 curves generated using Graphpad Prism version 7.0. The assay had a Z score of 0.79 with the 30 
minute pre-incubation and 0.75 without pre-incubation. 
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